KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 153 filers reported holding KRYSTAL BIOTECH INC in Q3 2022. The put-call ratio across all filers is 3.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $604,360 | +0.3% | 5,210 | 0.0% | 0.18% | +41.7% |
Q2 2023 | $602,641 | -13.3% | 5,210 | -40.0% | 0.13% | -45.5% |
Q1 2023 | $694,921 | +0.2% | 8,680 | 0.0% | 0.23% | -11.4% |
Q4 2022 | $693,532 | +35.5% | 8,680 | +19.5% | 0.26% | +41.4% |
Q3 2022 | $512,000 | +74.1% | 7,262 | +62.1% | 0.19% | +91.8% |
Q2 2022 | $294,000 | +10.5% | 4,480 | +12.0% | 0.10% | +64.4% |
Q1 2022 | $266,000 | – | 4,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 771,250 | $53,949,000 | 4.15% |
First Light Asset Management, LLC | 680,170 | $47,578,000 | 3.41% |
ACT CAPITAL MANAGEMENT, LLC | 59,000 | $4,127,000 | 2.98% |
S Squared Technology, LLC | 95,215 | $6,660,000 | 2.98% |
Redmile Group, LLC | 1,820,898 | $127,372,000 | 2.90% |
Soleus Capital Management, L.P. | 228,437 | $15,979,000 | 1.60% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 50,922 | $3,562,000 | 1.59% |
Artal Group S.A. | 700,000 | $48,965,000 | 1.33% |
SILVERARC CAPITAL MANAGEMENT, LLC | 46,670 | $3,265,000 | 1.32% |
Kynam Capital Management, LP | 34,816 | $2,435,000 | 1.30% |